Market Access Implementation
Navigating Local Stakeholders and Their Needs
Recent changes in the healthcare arena have resulted in a major power shift among key stakeholders involved in Market Access. Previously, the clinician was the critical contact point in determining whether a new product would reach patients. More recently, payers have become a highly influential force in medical decisions. Simply put, making inroads with clinicians is useless if the payers controlling budgets and creating opportunities for product use are not on board as well.
Many pharmaceutical companies are now scrambling to reach payers with the key messages and information needed to secure their support. Not surprisingly, those who successfully navigate the new terrain recognize the approaches for clinicians don’t work with payers seeking:
- Evidence of efficacy and innovation versus existing treatments.
- Proof of decreasing overall expenditures and addressing issues associated with aging populations and demands on healthcare.
Our established relationships with local decision makers across a variety of healthcare systems allow us to create effective pre-launch strategies and deliver data for product approval. We help customers:
- Develop a deep understanding of local regulatory requirements, national healthcare systems.
- Collect data, develop cost scenarios, and create health economic models.
- Integrate a commercial mindset early in the clinical development process.
Most importantly, Quintiles has strong local Market Access teams with established payer relationships. These relationships with high level prescribing and non-prescribing influencers and decision makers in different markets around the world provide the access to present value dossiers and meet with institutions to ensure product adoption and reimbursement – creating stronger national and regional plans.
Contact us today to discuss how Quintiles can help you successfully navigate the world of Market Access.
